Beacon Capital Management LLC (Tennessee)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-174
Closed -$70.6K 918
2025
Q2
$70.6K Sell
174
-63
-27% -$26.3K 0.01% 273
2025
Q1
$118K Buy
237
+38
+19% +$20.6K 0.02% 175
2024
Q4
$104K Sell
199
-88
-31% -$48.4K 0.01% 189
2024
Q3
$178K Buy
287
+84
+41% +$49.7K 0.03% 131
2024
Q2
$112K Buy
203
+5
+3% +$2.86K 0.02% 159
2024
Q1
$115K Buy
198
+56
+39% +$31.4K 0.02% 157
2023
Q4
$71.9K Sell
142
-100
-41% -$48.4K 0.02% 170
2023
Q3
$126K Hold
242
0.03% 131
2023
Q2
$126K Buy
242
+20
+9% +$10.8K 0.03% 131
2023
Q1
$128K Sell
222
-12
-5% -$6.76K 0.04% 116
2022
Q4
$129K Buy
234
+68
+41% +$36K 0.04% 122
2022
Q3
$91K Sell
166
-7
-4% -$3.92K 0.03% 146
2022
Q2
$101K Hold
173
0.03% 157
2022
Q1
$101K Buy
+173
New +$99.4K 0.02% 157

Other funds holding TMO

Beacon Capital Management LLC (Tennessee)'s TMO Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 174 shares — an estimated $70.6K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in TMO in Q1 2022 and held it in 14 quarters. The position peaked at $178K in Q3 2024. 2,509 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 174 Thermo Fisher Scientific shares in Q3 2025, an estimated $70.6K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 14 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Thermo Fisher Scientific position peaked at $178K in Q3 2024.
  • 2,509 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.